Medical Fluid Bags Market Size - By Product, By Material, By End-Use, & Forecast, 2023

List of Tables

Global Medical Fluid Bags Market is poised to exhibit a decent growth rate between 2023 and 2032, attributed to the rising number of premature births.

Preterm birth and related complications are the leading cause of death among newborns in Asia Pacific countries. According to the WHO report, India contributes 60% of the world's premature deliveries. In India, an estimated 15 million babies are born preterm every year. Babies that survive premature births may face chronic conditions that require long-term follow-up. These adverse events, in line with the rise in chronic diseases in premature babies, are anticipated to expedite the adoption rate of medical fluid bags for precise fluid, electrolyte, and nutrition management.

The overall medical fluid bags market is categorized based on product, material, end-use, and region.

Regarding the product, the dialysis bags segment could reach over USD 930 million by 2032. The rising prevalence of diabetes and hypertension, which are risk factors for kidney diseases, is driving the demand for dialysis and related supplies. Improved access to healthcare services has contributed to the increased demand for dialysis treatments, which will favor the uptake of medical fluid bags. Furthermore, advancements in dialysis technology have improved treatment options and efficiency, further boosting the need for these products.

With respect to material, the medical fluid bags market share from the PVC compounds segment is estimated to be worth over USD 1.5 billion by 2032. PVC compounds are widely used in medical fluid bags due to their excellent compatibility with various fluids, ensuring the integrity and safety of contents. The flexibility of PVC allows for diverse bag sizes and shapes, catering to different healthcare settings. Moreover, PVC is cost-effective compared to alternative materials, enabling affordable production and widespread availability of medical fluid bags.

In terms of end-use, the market size from the clinics segment will depict an appreciable growth rate from 2023 to 2032, owing to the growing demand for urgent care and the rise in the number of clinics. According to the Urgent Care Association's (UCA) 2019 report, the number of clinics in the U.S. reached 9,616 in November 2019, highlighting a 9.6% surge from the previous year. Urgent care clinics address approximately 89 million patient visits in the country annually. The growing patient demand for quick access to healthcare services, better convenience, and cost-effectiveness is driving the uptake of medical fluid bags in urgent care clinics.

The European medical fluid bags market was valued at over USD 1.1 billion in 2022, driven by factors like the rising prevalence of chronic diseases, increasing surgical procedures, and the need for efficient fluid management in healthcare. Advancements in medical technology have led to innovative fluid bag systems, enhancing safety and ease of use. The growing geriatric population in Europe also contributes to the demand. Strict regulations by bodies like EMA and Ph. Eur. ensure safety and quality standards, which will contribute to the expansion of the medical fluid bags market in Europe.

Product Code: 1677

Chapter 1 Methodology

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Medical fluid bags industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Material trends
- 2.1.5 End-use trends

Chapter 3 Medical Fluid Bags Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing geriatric population
  - 3.2.1.2 Surging prevalence of chronic diseases
  - 3.2.1.3 Rising number of premature births
  - 3.2.1.4 Growing number of healthcare centers and surgical procedures
  - 3.2.1.5 Augmenting healthcare awareness in developing countries
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Environmental impact related to improper disposal
  - 3.2.2.2 Health concerns associated with the use of BPA and DEHP medical bags
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By material
- 3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Future market trends
3.9 Gap analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022

Chapter 5 Medical Fluid Bags Market Size and Forecast, By Product (USD Million & Kilotons)

5.1 Key trends, by product
5.2 Blood Bags
5.3 Intravenous Bags
5.4 Drain Bags
- 5.4.1 Surgical
- 5.4.2 Urinary
5.5 Enema Bags
5.6 Biohazard Disposable Bags
5.7 Breast Milk Bags
5.8 Reagent Bags
5.9 Dialysis Bags
5.10 Others

Chapter 6 Medical Fluid Bags Market Size and Forecast, By Material (USD Million & Kilotons)

6.1 Key trends, by material
6.2 PVC compounds
6.3 Polyolefins
6.4 Thermoplastic elastomers
6.5 Thermoplastic polyurethanes
6.6 Others

Chapter 7 Medical Fluid Bags Market Size and Forecast, By End-use (USD Million & Kilotons)

7.1 Key trends, by end-use
7.2 Hospitals
7.3 Blood banks
7.4 Clinics
7.5 Homecare settings
7.6 Diagnostic centers
7.7 Others

Chapter 8 Medical Fluid Bags Market Size and Forecast, By Region (USD Million & Kilotons)

8.1 Key regional trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Poland
- 8.3.7 Sweden
- 8.3.8 The Netherlands
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Indonesia
- 8.4.7 Philippines
- 8.4.8 Vietnam
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.5.5 Chile
- 8.5.6 Peru
8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Turkey
- 8.6.5 Israel
- 8.6.6 Iran

Chapter 9 Company Profiles

9.1 Amcor Ltd.
9.2 Amsino International Inc
9.3 Baxter International.
9.4 B. Braun Melsungen AG
9.5 Coloplast
9.6 ConvaTec
9.7 Becton Dickinson, and Company
9.8 Fresenius Kabi
9.9 Kraton Corporation
9.10 Maco Pharma
9.11 Pall Corporation
9.12 Renolit
9.13 Smith's Medical
9.14 Technoflex
9.15 Terumo Corporation
9.16 Thermo Fisher Scientific Inc